학술논문

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: Results from Study 111/KEYNOTE-146
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 19 January 2024, 12(1))
Subject
Language
English
ISSN
20511426